Terry Smith acquired 1.47M Idexx Laboratories shares worth $816M. That's 5.79% of their entire equity portfolio (10th largest holding). The investor owns 1.84% of the outstanding Idexx Laboratories stock. The first Idexx Laboratories trade was made in Q1 2015. Since then Terry Smith bought shares 22 more times and sold shares on 22 occasions. The stake costed the investor $204M, netting the investor a gain of 300% so far.